Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Dosage for Rebound Pain in Foot and Ankle Surgery
NCT04872322Phase 3Unknown
- Sponsor
- Rothman Orthopaedics
- Start
- Aug 2017
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in postoperative pain, sponsored by Rothman Orthopaedics. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04872322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04872322.